| pubmed-article:14578227 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C0009247 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C1257987 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:14578227 | lifeskim:mentions | umls-concept:C1514923 | lld:lifeskim |
| pubmed-article:14578227 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:14578227 | pubmed:dateCreated | 2003-10-27 | lld:pubmed |
| pubmed-article:14578227 | pubmed:abstractText | To compare the incidence of heart failure in individuals with type 2 diabetes receiving thiazolidinediones (TZDs) versus other oral antihyperglycemic agents. | lld:pubmed |
| pubmed-article:14578227 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14578227 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14578227 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14578227 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14578227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14578227 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14578227 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:14578227 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:14578227 | pubmed:author | pubmed-author:PhillipsLawre... | lld:pubmed |
| pubmed-article:14578227 | pubmed:author | pubmed-author:DeleaThomas... | lld:pubmed |
| pubmed-article:14578227 | pubmed:author | pubmed-author:OsterGerryG | lld:pubmed |
| pubmed-article:14578227 | pubmed:author | pubmed-author:EdelsbergJohn... | lld:pubmed |
| pubmed-article:14578227 | pubmed:author | pubmed-author:HagiwaraMayM | lld:pubmed |
| pubmed-article:14578227 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14578227 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:14578227 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14578227 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14578227 | pubmed:pagination | 2983-9 | lld:pubmed |
| pubmed-article:14578227 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:meshHeading | pubmed-meshheading:14578227... | lld:pubmed |
| pubmed-article:14578227 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14578227 | pubmed:articleTitle | Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. | lld:pubmed |
| pubmed-article:14578227 | pubmed:affiliation | Policy Analysis, Brookline, Massachusetts 02455, USA. tdelaea@pai2.com | lld:pubmed |
| pubmed-article:14578227 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14578227 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14578227 | lld:pubmed |
